163 related articles for article (PubMed ID: 23966458)
21. Autoantibodies against complement components in systemic lupus erythematosus - role in the pathogenesis and clinical manifestations.
Hristova MH; Stoyanova VS
Lupus; 2017 Dec; 26(14):1550-1555. PubMed ID: 29092674
[TBL] [Abstract][Full Text] [Related]
22. The Complement System in Lupus Nephritis.
Birmingham DJ; Hebert LA
Semin Nephrol; 2015 Sep; 35(5):444-54. PubMed ID: 26573547
[TBL] [Abstract][Full Text] [Related]
23. [Systemic lupus erythematosus].
Kneitz C; Goebeler M; Tony HP
Internist (Berl); 2003 Dec; 44(12):1557-71; quiz 1572-3. PubMed ID: 15132164
[No Abstract] [Full Text] [Related]
24. The nephritis of systemic lupus erythematosus--a review.
Feng PH; Sinniah R
Ann Acad Med Singap; 1982 Jan; 11(1):86-93. PubMed ID: 7041781
[TBL] [Abstract][Full Text] [Related]
25. Health-related quality of life in patients with systemic lupus erythematosus and proliferative lupus nephritis.
Daleboudt GM; Berger SP; Broadbent E; Kaptein AA
Psychol Health Med; 2011 Aug; 16(4):393-404. PubMed ID: 21749237
[TBL] [Abstract][Full Text] [Related]
26. Hyperacute renal failure as the initial presentation of systemic lupus erythematosus.
Arbel O; Pizov G; Ben-Yehuda A; Rubinow A; Naparstek Y; Amital H
Lupus; 2005; 14(4):331-3. PubMed ID: 15864922
[TBL] [Abstract][Full Text] [Related]
27. [Systemic lupus erythematosus in children and adolescents].
Sallmann S; Fiebig B; Hedrich CM; Heubner G; Gahr M
Z Rheumatol; 2006 Nov; 65(7):576-8, 580-2, 584-5. PubMed ID: 17072573
[TBL] [Abstract][Full Text] [Related]
28. Complement deficiencies and abnormalities of the complement system in systemic lupus erythematosus and related disorders.
Walport MJ; Lachmann PJ
Curr Opin Rheumatol; 1990 Aug; 2(4):661-3. PubMed ID: 2206809
[No Abstract] [Full Text] [Related]
29. Lymphopaenia, anti-Ro/anti-RNP autoantibodies, renal involvement and cyclophosphamide use correlate with increased risk of herpes zoster in patients with systemic lupus erythematosus.
Hu SC; Lin CL; Lu YW; Chen GS; Yu HS; Wu CS; Lan CC
Acta Derm Venereol; 2013 May; 93(3):314-8. PubMed ID: 22983107
[TBL] [Abstract][Full Text] [Related]
30. The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus.
Weng MY; Weng CT; Liu MF
Clin Rheumatol; 2010 Jul; 29(7):771-5. PubMed ID: 20195879
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-27 and interleukin-23 in patients with systemic lupus erythematosus: possible role in lupus nephritis.
Xia LP; Li BF; Shen H; Lu J
Scand J Rheumatol; 2015 May; 44(3):200-5. PubMed ID: 25562331
[TBL] [Abstract][Full Text] [Related]
32. Staphylococcal scalded skin syndrome in the course of lupus nephritis.
Rydzewska-Rosołowska A; Brzosko S; Borawski J; Myśliwiec M
Nephrology (Carlton); 2008 Jun; 13(3):265-6. PubMed ID: 18315709
[No Abstract] [Full Text] [Related]
33. [Cyclophosphamide therapy in systemic lupus erythematosus].
Backhaus M; Hiepe F
Z Rheumatol; 1997; 56(4):178-89. PubMed ID: 9417758
[TBL] [Abstract][Full Text] [Related]
34. Pincer nail in a lupus patient.
Azevedo THV; Neiva CLS; Consoli RV; Couto ACD; Dias AFMP; Souza EJR
Lupus; 2017 Dec; 26(14):1562-1563. PubMed ID: 28420048
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.
Aringer M; Graninger WB; Steiner G; Smolen JS
Arthritis Rheum; 2004 Oct; 50(10):3161-9. PubMed ID: 15476222
[TBL] [Abstract][Full Text] [Related]
36. Treatment with anti-interleukin 23 antibody ameliorates disease in lupus-prone mice.
Kyttaris VC; Kampagianni O; Tsokos GC
Biomed Res Int; 2013; 2013():861028. PubMed ID: 23841097
[TBL] [Abstract][Full Text] [Related]
37. Systemic lupus erythematosus complicated by a Gitelman-like syndrome in an 8-year-old girl.
Barathidasan GS; Krishnamurthy S; Karunakar P; Rajendran R; Ramya K; Dhandapany G; Ramamoorthy JG; Ganesh RN
CEN Case Rep; 2020 May; 9(2):129-132. PubMed ID: 31853802
[TBL] [Abstract][Full Text] [Related]
38. Cat scratch disease in an immunosuppressed patient with systemic lupus erythematosus.
Vargas-Hitos JA; Sabio JM; Navarrete-Navarrete N; Arenas-Miras Mdel M; Zamora-Pasadas M; Jiménez-Alonso J
Lupus; 2016 Mar; 25(3):310-1. PubMed ID: 26453661
[TBL] [Abstract][Full Text] [Related]
39. Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus.
Tydén H; Lood C; Gullstrand B; Jönsen A; Ivars F; Leanderson T; Bengtsson AA
Lupus; 2017 Feb; 26(2):139-149. PubMed ID: 27407135
[TBL] [Abstract][Full Text] [Related]
40. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
